Enzo Total Current Liabilities vs Total Liab Analysis

ENZ Stock  USD 1.04  0.06  6.12%   
Enzo Biochem financial indicator trend analysis is much more than just examining Enzo Biochem latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enzo Biochem is a good investment. Please check the relationship between Enzo Biochem Total Current Liabilities and its Total Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Total Current Liabilities vs Total Liab

Total Current Liabilities vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enzo Biochem Total Current Liabilities account and Total Liab. At this time, the significance of the direction appears to have very week relationship.
The correlation between Enzo Biochem's Total Current Liabilities and Total Liab is 0.26. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Liab in the same time period over historical financial statements of Enzo Biochem, assuming nothing else is changed. The correlation between historical values of Enzo Biochem's Total Current Liabilities and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Enzo Biochem are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Total Current Liabilities i.e., Enzo Biochem's Total Current Liabilities and Total Liab go up and down completely randomly.

Correlation Coefficient

0.26
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Current Liabilities

Total Current Liabilities is an item on Enzo Biochem balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Enzo Biochem are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from Enzo Biochem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 54.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit42.0M11.6M14.6M13.9M
Total Revenue107.1M31.1M31.9M63.1M

Enzo Biochem fundamental ratios Correlations

0.050.250.320.830.49-0.54-0.150.670.21-0.10.81-0.180.470.020.140.260.30.230.420.9-0.590.010.10.420.47
0.05-0.27-0.24-0.440.410.550.66-0.050.460.790.02-0.55-0.550.97-0.14-0.03-0.620.860.23-0.14-0.45-0.380.36-0.57-0.58
0.25-0.270.510.190.11-0.41-0.360.3-0.19-0.250.3-0.490.26-0.260.010.480.20.050.40.270.33-0.48-0.070.350.36
0.32-0.240.510.180.51-0.11-0.710.020.42-0.60.060.120.74-0.420.510.20.750.260.440.180.190.20.510.70.73
0.83-0.440.190.180.11-0.77-0.330.65-0.12-0.390.720.170.57-0.430.10.160.46-0.340.120.87-0.380.25-0.20.530.58
0.490.410.110.510.110.36-0.35-0.170.87-0.14-0.01-0.280.450.270.670.540.360.630.820.1-0.3-0.080.630.430.44
-0.540.55-0.41-0.11-0.770.360.14-0.860.610.25-0.78-0.05-0.340.490.350.0-0.250.440.16-0.80.1-0.020.49-0.35-0.37
-0.150.66-0.36-0.71-0.33-0.350.140.24-0.240.950.22-0.38-0.860.77-0.63-0.44-0.90.33-0.38-0.01-0.33-0.34-0.27-0.88-0.9
0.67-0.050.30.020.65-0.17-0.860.24-0.430.190.95-0.250.110.0-0.48-0.05-0.040.01-0.050.88-0.41-0.18-0.360.10.11
0.210.46-0.190.42-0.120.870.61-0.24-0.43-0.08-0.30.00.280.280.720.160.30.60.55-0.19-0.180.220.740.180.22
-0.10.79-0.25-0.6-0.39-0.140.250.950.19-0.080.19-0.55-0.80.88-0.51-0.27-0.870.52-0.15-0.04-0.38-0.5-0.19-0.8-0.83
0.810.020.30.060.72-0.01-0.780.220.95-0.30.19-0.280.160.07-0.370.0-0.020.110.030.96-0.56-0.17-0.250.150.16
-0.18-0.55-0.490.120.17-0.28-0.05-0.38-0.250.0-0.55-0.280.35-0.630.16-0.540.5-0.54-0.55-0.120.070.920.150.250.28
0.47-0.550.260.740.570.45-0.34-0.860.110.28-0.80.160.35-0.660.620.340.97-0.170.390.39-0.020.380.210.980.99
0.020.97-0.26-0.42-0.430.270.490.770.00.280.880.07-0.63-0.66-0.260.01-0.760.760.18-0.11-0.45-0.510.17-0.65-0.67
0.14-0.140.010.510.10.670.35-0.63-0.480.72-0.51-0.370.160.62-0.260.380.660.10.62-0.150.190.260.280.560.58
0.26-0.030.480.20.160.540.0-0.44-0.050.16-0.270.0-0.540.340.010.380.20.10.840.080.11-0.56-0.020.470.44
0.3-0.620.20.750.460.36-0.25-0.9-0.040.3-0.87-0.020.50.97-0.760.660.2-0.260.270.220.140.530.250.920.94
0.230.860.050.26-0.340.630.440.330.010.60.520.11-0.54-0.170.760.10.1-0.260.470.01-0.35-0.360.53-0.2-0.2
0.420.230.40.440.120.820.16-0.38-0.050.55-0.150.03-0.550.390.180.620.840.270.470.120.02-0.460.210.430.44
0.9-0.140.270.180.870.1-0.8-0.010.88-0.19-0.040.96-0.120.39-0.11-0.150.080.220.010.12-0.54-0.01-0.210.360.39
-0.59-0.450.330.19-0.38-0.30.1-0.33-0.41-0.18-0.38-0.560.07-0.02-0.450.190.110.14-0.350.02-0.54-0.09-0.180.020.01
0.01-0.38-0.480.20.25-0.08-0.02-0.34-0.180.22-0.5-0.170.920.38-0.510.26-0.560.53-0.36-0.46-0.01-0.090.330.250.29
0.10.36-0.070.51-0.20.630.49-0.27-0.360.74-0.19-0.250.150.210.170.28-0.020.250.530.21-0.21-0.180.330.160.18
0.42-0.570.350.70.530.43-0.35-0.880.10.18-0.80.150.250.98-0.650.560.470.92-0.20.430.360.020.250.160.99
0.47-0.580.360.730.580.44-0.37-0.90.110.22-0.830.160.280.99-0.670.580.440.94-0.20.440.390.010.290.180.99
Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets112.5M113.7M95.9M121.9M85.8M100.6M
Short Long Term Debt Total32.8M22.7M20.6M7.0M3.5M3.3M
Other Current Liab10.3M8.1M8.2M34.5M22.5M23.6M
Total Current Liabilities32.8M26.1M24.6M40.0M24.8M15.1M
Total Stockholder Equity58.4M68.6M54.5M78.5M56.1M74.8M
Property Plant And Equipment Net34.4M33.6M32.4M16.7M15.2M12.5M
Net Debt(15.1M)9.2M(1.0M)(75.4M)(48.9M)(46.4M)
Retained Earnings(278.3M)(270.4M)(288.6M)(268.4M)(294.4M)(279.7M)
Cash47.9M13.5M21.6M82.4M52.4M42.5M
Non Current Assets Total43.8M43.1M41.5M23.4M15.7M14.9M
Non Currrent Assets Other1.4M1.8M1.6M1.7M530K503.5K
Cash And Short Term Investments47.9M43.5M21.6M82.4M52.4M46.6M
Net Receivables9.1M10.2M4.8M4.8M4.0M3.8M
Common Stock Shares Outstanding47.7M48.3M48.6M49.2M50.9M37.4M
Liabilities And Stockholders Equity112.5M113.7M95.9M121.9M85.8M100.6M
Non Current Liabilities Total21.4M19.0M16.8M3.4M4.9M7.8M
Inventory7.8M12.7M15.4M7.9M6.8M5.6M
Other Current Assets4.0M4.2M6.9M3.3M6.8M7.2M
Other Stockholder Equity334.5M337.1M339.5M344.4M348.1M220.0M
Total Liab54.2M45.1M41.4M43.4M29.7M18.8M
Property Plant And Equipment Gross34.4M33.6M63.9M34.0M32.0M33.6M
Total Current Assets68.8M70.6M54.4M98.5M70.0M68.6M
Accumulated Other Comprehensive Income1.7M1.4M3.2M1.9M1.9M2.0M
Intangible Assets1.0M538K244K7.5M6.7M6.7M
Accounts Payable8.5M8.1M3.7M3.6M1.4M1.3M
Short Term Debt11.5M7.2M1.1M2.0M917K871.2K
Common Stock Total Equity476K479K485K487K560.1K422.6K
Common Stock479K485K487K499K521K433.3K
Other Assets1.4M1.8M1.6M6.7M6.0M6.3M
Property Plant Equipment14.5M33.6M17.3M16.7M19.2M10.2M
Current Deferred Revenue(391K)2.5M2.7M11.7M5.9M3.7M
Long Term Debt4.5M4.4M4.1M269K189K179.6K
Net Tangible Assets50.4M60.9M47.0M78.5M90.2M58.6M
Retained Earnings Total Equity(252.2M)(249.7M)(278.3M)(288.6M)(259.8M)(272.8M)
Capital Surpluse334.5M337.1M339.5M344.4M396.1M359.7M
Non Current Liabilities Other424K16.9M5K12.8M14.7M15.4M
Short Long Term Debt7.1M152K229K2.6M76K72.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.